Ftse Mib
34.012,11
-0,67%
DAX
18.448,15
0,05%
S&P 500
5.177,04
-0,21%
NASDAQ
16.234,00
-0,60%
Bitcoin
62.005,11
-0,53%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alaunos Therapeutics Inc (TCRT) Alaunos Therapeutics Inc (TCRT) Notizie

TCRT

Alaunos Therapeutics (TCRT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TCRT
DataOraFonteTitoloSimboloCompagnia
29/02/202403:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
22/02/202422:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
14/02/202418:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
23/01/202423:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
14/11/202313:30GlobeNewswire Inc.Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
01/09/202318:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202322:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202322:05GlobeNewswire Inc.Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
29/06/202313:00GlobeNewswire Inc.Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesNASDAQ:TCRTAlaunos Therapeutics Inc
12/06/202322:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRTAlaunos Therapeutics Inc
08/06/202323:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
25/05/202323:00GlobeNewswire Inc.Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202313:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202313:00GlobeNewswire Inc.Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
03/05/202314:30GlobeNewswire Inc.Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
26/04/202318:30GlobeNewswire Inc.Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
25/04/202323:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCRTAlaunos Therapeutics Inc
19/04/202322:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TCRTAlaunos Therapeutics Inc
14/04/202323:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TCRTAlaunos Therapeutics Inc
30/03/202313:00GlobeNewswire Inc.Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of DirectorsNASDAQ:TCRTAlaunos Therapeutics Inc
29/03/202323:30GlobeNewswire Inc.Alaunos Therapeutics to Participate in Upcoming Investor Conferences in AprilNASDAQ:TCRTAlaunos Therapeutics Inc
07/03/202313:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TCRTAlaunos Therapeutics Inc
07/03/202313:00GlobeNewswire Inc.Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
28/02/202322:01GlobeNewswire Inc.Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
14/02/202319:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRTAlaunos Therapeutics Inc
09/01/202314:30GlobeNewswire Inc.Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023NASDAQ:TCRTAlaunos Therapeutics Inc
29/11/202215:01GlobeNewswire Inc.Alaunos Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:TCRTAlaunos Therapeutics Inc
28/11/202222:01GlobeNewswire Inc.Alaunos Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:TCRTAlaunos Therapeutics Inc
15/11/202212:25TipRanksH.C. Wainwright Sticks to Their Hold Rating for Alaunos Therapeutics (TCRT)NASDAQ:TCRTAlaunos Therapeutics Inc
14/11/202213:00GlobeNewswire Inc.Alaunos Therapeutics Reports Third Quarter 2022 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TCRT

La tua Cronologia

BIT
UCG
Unicredit
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
CPR
Davide Campari
BIT
FBK
Finecobank
BIT
IRE
Iren
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network